[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-355936-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-355936-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","metabolic-regulation-of-tumor-associated-macrophage-function-and-immunotherapy-in-cancer","Metabolic regulation of tumor-associated macrophage function and immunotherapy in cancer","","Tumor-associated macrophages (TAMs), key components of the tumor immune microenvironment (TIME), undergo metabolic reprogramming that supports functional adaptation. Tumor cells reshape TAM metabolism through metabolic cross-feeding, cytokines, extracellular vesicles, and signaling mediators such as GRP78 and lipopolysaccharide. These changes alter TAM signaling, phenotype, and immune crosstalk with T cells, NK cells, and fibroblasts, driving cancer progression and immune evasion. The review surveys preclinical and clinical TAM-centered studies and evaluates therapeutic advantages and challenges, aiming to guide next-generation cancer immunotherapy target discovery.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/metabolic-regulation-of-tumor-associated-macrophage-function-and-immunotherapy-in-cancer/355936/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/metabolic-regulation-of-tumor-associated-macrophage-function-and-immunotherapy-in-cancer/355936.png","ImageObject",300,407,{"name":42,"@type":43},"Aldword","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-19","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",14,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How do tumor cells influence tumor-associated macrophage metabolism in the tumor immune microenvironment?","Question",{"text":63,"@type":64},"Tumor cells modulate TAMs via multiple routes, including metabolic cross-feeding, cytokine production, extracellular vesicles, and signaling mediators such as GRP78 and lipopolysaccharide.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What metabolic shifts are described for TAMs during functional adaptation?",{"text":68,"@type":64},"TAMs can switch toward enhanced glycolysis or toward oxidative phosphorylation (OXPHOS) and fatty acid oxidation (FAO), depending on microenvironmental conditions such as hypoxia and oxygen availability.",{"name":70,"@type":61,"acceptedAnswer":71},"Why is targeting metabolic reprogramming in TAMs considered promising for cancer immunotherapy?",{"text":72,"@type":64},"The review links TAM metabolism to cancer progression and immune evasion, suggesting that metabolic targeting may strengthen immune responses, reduce angiogenesis and metastasis, and improve synergy with other therapies.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},355936,1790167669,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},2336478940917,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Cancer Biol Med 2026. doi: 10.20892/j.issn.2095-3941.2025.0626  \nREVIEW  \nMetabolic regulation of tumor-associated macrophage function and immunotherapy in cancer  \nMingyue Zhao*, Rui Chen*, Ping Gao  \nMedical Research Institute, Guangdong Provincial People’s Hospital, Academy of Medical Sciences, Southern Medical University, Guangzhou 510000, China  \n\n| ABSTRACT | Tumor-associated macrophages (TAMs), essential components of the tumor immune microenvironment (TIME), undergo metabolic reprogramming as part of functional adaptation. Tumor cells modulate TAMs through multiple mechanisms, including metabolic cross-feeding, cytokine production, extracellular vesicles, tumor-derived proteins (such as GRP78) and pathogen-associated patterns (such as Lipopolysaccharide) signaling mediators. In turn, metabolic alterations in TAMs fine-tune TAM function via intricate signaling networks with outcomes that vary across cancer types. These functional and phenotypic shifts enable TAMs to influence malignant cells and other TIME components, such as T cells, NK cells, and fibroblasts, through the secretion of inflammatory factors and changes in surface marker expression. This process establishes an extensive network of interconnected cellular crosstalk. In this review the metabolic alterations-intracellular signaling-TAM biology axis is linked to cancer progression contributions and the implications for immunotherapy across diverse malignancies. Building on these insights, current preclinical and clinical studies with a focus on TAMs were surveyed and the advantages and challenges ofTAM-targeted therapeutic strategies were systematically evaluated. We anticipate that these perspectives will spur further investigation into TAM-specific immune targets and accelerate the development of next-generation cancer immunotherapies. |\n| --- | --- |\n| KEYWORDS | Tumor-associated macrophage; tumor microenvironment; metabolic rewiring; immunotherapy |\n\nIntroduction  \nAs an abundant immune components in most cancer types, tumor-associated macrophages (TAMs) have a vital role in cancer development as well as therapeutic resistance 1-3. Global metabolic rewiring takes place in TAMs during the phenotype transition in tumor tissue from pro- to anti-tumor or vice versa4,5 . A lack of nutrients and oxygen in the tumor microenvironment (TME) results from dysfunctional vasculature, the dramatically increased metabolic demand of malignant cells, and competition from immune and stromal cells6,7 . This hostile TME favours adaptive cancer cell survival and proliferative mechanisms to promote tumor progression, metastasis, and therapeutic resistance8,9 . In addition, cancer cells secrete toxic metabolic byproducts, such as adenosine  \n*These authors contributed equally to this work. Correspondence to: Mingyue Zhao and Ping Gao  \nE-mail: [zhaomingyue@gdph.org.cn](zhaomingyue@gdph.org.cn) and [pgao2@ustc.edu.cn](pgao2@ustc.edu.cn)  \nORCID ID: [https://orcid.org/0000-0002-5173-9820](https://orcid.org/0000-0002-5173-9820) and [https://orcid](https://orcid).  \norg/0000-0002-6930-7989  \nReceived June 26, 2025; accepted March 3, 2026;  \npublished online April 13, 2026. Available [at www.cancerbiomed.org](at www.cancerbiomed.org)  \n©2026 The Authors. Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4 .0)  \nand lactate, to maintain an immunosuppressive TME and evade immune surveillance 10-12. In particular, TAMs are commonly educated by the TME to support tumor growth. This reprogramming involves a metabolic switch that is intrinsically linked to and enables a phenotypic shift towards a protumor state 13-16. For example, hypoxic conditions in the TME stabilize hypoxia-inducible factor 1-alpha (HIF-1α) in TAMs, which upregulates glycolytic enzymes and glucose transporters (e.g., Glucose Transporter 1) to promote glycolysis 17,18 . While perivascular TAMs in oxygen-rich niches may use oxidative phosphorylation (OXPHOS) for energy, this process is suppo","cbCaio5MlaTddYtf","https://ap.wps.com/l/cbCaio5MlaTddYtf","pdf",1426953,23,"English","# Introduction\n## Metabolic regulation of TAM function in cancer\n# Metabolic reprogramming of TAMs in cancer","[{\"question\":\"How do tumor cells influence tumor-associated macrophage metabolism in the tumor immune microenvironment?\",\"answer\":\"Tumor cells modulate TAMs via multiple routes, including metabolic cross-feeding, cytokine production, extracellular vesicles, and signaling mediators such as GRP78 and lipopolysaccharide.\"},{\"question\":\"What metabolic shifts are described for TAMs during functional adaptation?\",\"answer\":\"TAMs can switch toward enhanced glycolysis or toward oxidative phosphorylation (OXPHOS) and fatty acid oxidation (FAO), depending on microenvironmental conditions such as hypoxia and oxygen availability.\"},{\"question\":\"Why is targeting metabolic reprogramming in TAMs considered promising for cancer immunotherapy?\",\"answer\":\"The review links TAM metabolism to cancer progression and immune evasion, suggesting that metabolic targeting may strengthen immune responses, reduce angiogenesis and metastasis, and improve synergy with other therapies.\"}]","Metabolic regulation of tumor-associated macrophage function and immunotherapy in cancer | PDF",1790121823,58,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7aef87f8ab0b33a8a2ba91653dbb660c.webp",983,1287,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f0074e83aab3222f40fcd966ac3fbf49.webp",982,1286,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e0576b882d12c437101d6fec7bcb5487.webp",981,1284,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fcf27f908fe712569e092c7bc63c8b22.webp",980,1283]